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ABSTRACT 
 
PURPOSE: The medical literature relevant to germline genetics is growing exponentially. Clinicians need tools 
monitoring and prioritizing the literature to understand the clinical implications of the pathogenic genetic 
variants. We developed and evaluated two machine learning models to classify abstracts as relevant to the 
penetrance (risk of cancer for germline mutation carriers) or prevalence of germline genetic mutations. 
METHODS: We conducted literature searches in PubMed and retrieved paper titles and abstracts to create an 
annotated dataset for training and evaluating the two machine learning classification models. Our first model is 
a support vector machine (SVM) which learns a linear decision rule based on the bag-of-ngrams representation 
of each title and abstract. Our second model is a convolutional neural network (CNN) which learns a complex 
nonlinear decision rule based on the raw title and abstract. We evaluated the performance of the two models on 
the classification of papers as relevant to penetrance or prevalence. 
RESULTS: For penetrance classification, we annotated 3740 paper titles and abstracts and used 60% for 
training the model, 20% for tuning the model, and 20% for evaluating the model. The SVM model achieves 
89.53% accuracy (percentage of papers that were correctly classified) while the CNN model achieves 88.95 % 
accuracy. For prevalence classification, we annotated 3753 paper titles and abstracts. The SVM model achieves 
89.14% accuracy while the CNN model achieves 89.13 % accuracy. 
CONCLUSION: Our models achieve high accuracy in classifying abstracts as relevant to penetrance or 
prevalence. By facilitating literature review, this tool could help clinicians and researchers keep abreast of the 
burgeoning knowledge of gene-cancer associations and keep the knowledge bases for clinical decision support 
tools up to date. 
  
INTRODUCTION 
 The medical literature is growing exponentially, and nowhere is this more apparent than in genetics. In 
2010, a PubMed search for “BRCA1” yielded 7,867 papers, while in 2017 the same search retrieved nearly 
double that amount (14,266 papers). As the literature about individual genes increases, so does the number of 
pathogenic gene variants that are clinically actionable. Panel testing for hereditary cancer susceptibility genes 
identifies many patients with pathogenic variants in genes that are less familiar to clinicians, and it is not 
feasible for clinicians to understand the clinical implications of these pathogenic variants by conducting their 
own comprehensive literature review. Thus, clinicians need help monitoring, collating and prioritizing the 
medical literature. In addition, clinicians need clinical decision support tools to help facilitate decision-making 
for patients. These tools depend on a knowledge base of the metadata on these genetic mutations that is both up-
to-date and comprehensive.1  
 Natural language processing (NLP) is an area of Artificial Intelligence (AI) that focuses on problems 
involving the interpretation and “understanding” of free text by a non-human system.2,3 Traditional NLP 
approaches have relied almost exclusively on rules-based systems, where domain experts predefine a set of 
rules used to identify text with specific content. However, defining these rules is laborious and challenging as a 
result of variations in language, format and syntax.4 Modern NLP approaches instead rely on machine learning, 
where predictive models are learned directly from a set of texts that have been annotated for the specific target. 
 NLP has been applied in fields relevant to medical and health research.2,5,6 For example, in the field of 
oncology, researchers have used NLP to identify and classify cancer patients, assign staging, and determine 
cancer recurrence.7–9 NLP also has an important role in accelerating literature review by classifying papers as 
relevant to the topic of interest.10,11 Several studies developed and improved machine learning approaches based 
on the publicly available literature collections of 15 systematic literature reviews.11–14 These reviews were 
conducted by the Evidence-based Practice Centers to evaluate the efficacy of medications in 15 drug 
categories.13 Frunza et al. used a complement naïve Bayes approach to identify papers on the topic of the 
dissemination strategy of health care services for elderly people and achieved a precision of 63%.15 Fiszman et 
al. proposed an approach to identify papers relevant to cardiovascular risk factors (56% recall, 91% precision).16 
Miwa et al. extended an existing approach to classify social and public health literature on topics of cooking 
skills, sanitation, tobacco packaging, and youth development.17 
 However, no NLP approaches have been developed specifically for classifying literature regarding the 
penetrance (risk of cancer for germline mutation carriers) or prevalence of germline genetic mutations. To our 
knowledge, no annotated dataset is available for the purpose of developing a machine learning method to 
identify relevant papers in this domain. In this study, we aimed to create a human-annotated dataset of abstracts 
on cancer susceptibility genes and develop a machine learning-based NLP approach to classify abstracts as 
relevant to the penetrance or prevalence of pathogenic genetic mutations.  
MATERIALS AND METHODS 
 Institutional Review Board approval was not needed as no human data were analyzed. 
Establishing an annotated dataset 
 To develop effective machine learning models for automatic identification of relevant papers, we created 
a human-annotated dataset. We performed PubMed searches using the following query templates: 
• (“gene name”[TIAB] OR “medical subject headings (MeSH) for that gene” OR “related syndrome 
name”[TIAB] OR “MeSH for that syndrome”) AND ("Risk"[Mesh] OR "Risk"[TI] OR 
"Penetrance"[TIAB] OR "Hazard ratio"[TIAB]) AND ("cancer name"[Mesh] OR "cancer 
name"[TIAB])” 
• (“gene name”[TIAB] OR “medical subject headings (MeSH) for that gene” OR “related syndrome 
name”[TIAB] OR “MeSH for that syndrome”). 
We considered different gene-cancer combinations from the All Syndrome Known to Man Evaluator 
(ASK2ME),18 a recently developed clinical decision support tool for clinicians to estimate the age-specific 
cancer risk of germline mutation carriers. This tool captures most of the important gene-cancer combinations. 
We opted to use the title and abstract of each paper as the input for our models, for three main reasons. First, 
this information can be automatically downloaded through EDirect19, whereas automatically downloading the 
full-text papers was not feasible due to licensing issues. Second, the title and abstract of each paper can be 
downloaded in free text form, whereas full-text papers are not generally available in a common format, and one 
needs to handle PDF, HTML, as well as others. Last but not least, annotating the title and abstract is less time-
consuming than annotating the full-text, and therefore obtaining a large training dataset is feasible. Each paper 
(based on title and abstract) was annotated for the following fields by six human annotators, with a minimum of 
two human annotators per paper. Two fields (penetrance and prevalence) were used to classify papers as 
relevant to penetrance, prevalence, both, or neither. Other fields (polymorphism, ambiguous penetrance, 
ambiguous incidence) were annotated and used as exclusion criteria.   
• Penetrance: presence of information about risk of cancer for germline mutation carriers. 
• Prevalence: presence of information about proportion of germline mutation carriers in the general 
population or among individuals with cancer. 
• Polymorphism: presence of information only on a germline genetic variant present in more than 1% of 
the general population.  
• Ambiguous penetrance: a) unresolved disagreement between human annotators on the penetrance label 
or b) impossibility of determining the penetrance label solely based on the title and the abstract. 
• Ambiguous prevalence: a) unresolved disagreement between human annotators on the prevalence label 
or b) impossibility of determining the prevalence label solely based on the title and the abstract. 
 
Our goal was to develop models that could accurately classify papers with subject matter pertaining to the 
penetrance and prevalence of rare germline mutations. Papers annotated as polymorphism or ambiguous were 
not used for model training, tuning or evaluation. 
Models 
 Our first model is a support vector machine (SVM). We first tokenized the input title and abstract and 
converted them into a standard bag-of-ngram vector representation. Specifically, we represented each title and 
abstract by a vector, wherein each entry is the term frequency-inverse document frequency (tf-idf) of the 
corresponding ngram. Tf-idf increases in proportion to the frequency of the ngram in this particular abstract and 
is offset by the frequency of the ngram in the entire dataset. Thus, the resulting representation serves to down-
weight the feature value of common words that add little information, such as articles. Finally, we used this 
bag-of-ngram representation as the input for a linear SVMs to predict its corresponding label. 
 Our second model is a convolutional neural network (CNN).20 This model directly takes the tokenized 
title and abstract as its input and convolves the input with learnable local filters. It then combines the convolved 
representation globally and predicts the final label. Unlike the linear SVM, the CNN model is capable of 
learning nonlinear decision rules. 
Model Evaluation  
 For both the penetrance and the prevalence classification task, we split the dataset randomly into a 
model training set (60% of the data), a model tuning set (20% of the data), and a model evaluation (20% of the 
data). We trained the two models on the training set and used the model tuning set for hyper-parameter 
selection. The model performance was evaluated on the model evaluation set. We used accuracy (percentage of 
the papers that were correctly classified) and F1 score as our evaluation metrics. Here, the F1 score is the 
harmonic mean of precision (percent of predicted positive that are true positive) and recall (percent of all true 
positives that are predicted as positive). Learning curves were constructed showing how the number of papers 
annotated in the training set affects the accuracy of the models. We also plotted the receiver operating 
characteristic curve (ROC curve) to compare the model performance at various thresholds. 
RESULTS 
Dataset 
 The final human-annotated dataset contained 3,919 annotated papers (Table 1). Of these, 989 were on 
penetrance and 1291 were on prevalence. We excluded papers that were labeled as polymorphism-related. For 
the task of penetrance classification, we further excluded papers with an ambiguous penetrance label, reducing 
the annotated dataset to 3740. For the task of prevalence classification, we excluded papers with ambiguous 
prevalence label, reducing the annotated dataset to 3753 (Table 1). 
Model Performance 
 Table 2 shows the performance of the SVM and CNN model. The SVM model achieves 0.8953 
accuracy and 0.7886 F1 score in penetrance classification and 0.8914 accuracy and 0.8396 F1 score in 
prevalence classification. Although the CNN has more flexibility in modeling, it underperforms by a small 
margin compared to the SVM model. Figures 1a and 1b show the receiver operating characteristic curve (ROC 
curve) of the two models, for penetrance and prevalence classification respectively. The y-axis is the true 
positive rate, which is also known as sensitivity or recall. The x-axis is the false positive rate, which represents 
the probability of false alarm. The ROC curve provides a comparison of the model performance at different 
levels of decision threshold. Both models achieved similar area under the ROC curve (AUC) for both 
classification tasks. Figures 2a and 2b depict the learning curves for the two models for penetrance and 
prevalence classification respectively. For penetrance classification, when only 500 annotated papers are used 
for training, the SVM model achieved around 0.89 accuracy, while the CNN model achieves less than 0.85 
accuracy. However, the learning curve of the CNN model improves steadily as the training set increases. For 
prevalence classification, the two learning curves show a flattening trend after the number of papers reaches 
1000. 
DISCUSSION 
 The growing number of cancer susceptibility genes identified and the burgeoning literature regarding 
these genes is overwhelming for clinicians and even for researchers. Machine learning algorithms can help 
identify the relevant literature. In this study, we have created a dataset containing almost four thousand human 
annotated papers regarding cancer susceptibility genes. Using this dataset, we developed two models to classify 
papers as relevant to the penetrance or prevalence of cancer susceptibility genes. The SVM model we developed 
achieves 89.53% accuracy for penetrance and 89.14% accuracy for prevalence, outperforming the more 
complex CNN model. As we have shown in Figures 2a and 2b, our models perform better as the number of 
papers in the training set increases. Although the curves will plateau at some point, the increasing trend 
indicates that model performance will continue to improve as more annotated papers are added to the training 
set. 
 To maximize efficiency, SVM-based NLP approaches have been developed to identify relevant papers 
in the medical literature for various topics. In 2005, Aphinyanaphongs et al. developed the first SVM method to 
assist systematic literature review by identifying relevant papers in the domain of internal medicine.21 Several 
similar approaches were subsequently proposed, including an approach developed by Wallace et al. that 
incorporates active learning to reduce annotation cost.11,22 Wallace et al. reduced the number of papers that must 
be reviewed manually by around 50%, while capturing all important papers for systematic review.22 Fiszman et 
al. developed a system using symbolic relevance processing to identify potentially relevant papers for 
cardiovascular risk factor guidelines. The performance of his system was 56% recall and 91% precision.11,16  
While most existing methods have focused on the clinical literature, recently Miwa et al. extended the scope of 
their approach to include the social science literature.17   CNN-based NLP methods have been developed for 
short text and sentence classification.23–26 However, few methods have been developed and tested on classifying 
medical literature. Using the Risk of Bias (RoS) text classification datasets, Zhang et al. developed a CNN 
model to assess the study design bias in literature on randomized clinical trials (RCTs). The accuracy of the 
model ranged from 64% to 75%.27 
The high accuracy and F1 score of the models we developed show that these models can be used to 
classify prevalence and penetrance papers regarding cancer susceptibility genes. This approach will be a useful 
tool for physicians to prioritize literature and understand the clinical implications of pathogenic variants. Also, 
this NLP approach has the potential to assist systematic literature review and meta-analysis in the same domain. 
We have conducted another study to test its efficiency and comprehensiveness in identifying important papers 
for meta-analyses which will be reported separately (Deng Z, Yin K, Bao Y, et al. Validation of a Semi-
automated Natural Language Processing-based Procedure for Meta-Analysis of Cancer Susceptibility Gene 
Penetrance. Submitted to JCO Clin Cancer Informatics).  
Although our approach achieves high performance, there are some limitations. One weakness of our 
approach is the dependence on data available in the title and abstract. This is partly due to limitations in access 
to full-text publications, but also due to the variety of formats in which full-text publications are stored.  The 
proposed models do not work for papers that do not have an abstract or have an incomplete abstract. When the 
abstract is ambiguous for humans, misclassification can also occur. In the annotated training dataset, there are 
119 papers (3.0%) having ambiguous penetrance information, and 101 papers (2.6%) having ambiguous 
prevalence information. Although we excluded these from model training, classifying new abstracts that are 
ambiguous remains challenging. 
 The abstract is an important component of a published work, and is usually available publicly. A well-
written and complete abstract provides concise yet critical information pertinent to the study, can facilitate the 
capture of the key content by the reader, and can greatly facilitate NLP. When abstracts are not clearly written 
or leave out critical findings of the study, the efficacy of NLP models based on abstract text decreases. There is 
a need for authors to report their findings in sufficient detail if NLP methods are to be effective in the future.  
 One approach to handle important studies that do not have an abstract or do not report sufficient detail in 
the abstract is to develop classification algorithms based on the full text. Usually, full texts provide much more 
information on penetrance and prevalence. Developing algorithms to extract and read information from full 
texts may ultimately lead to higher accuracy. However, numerous issues will have to be solved to develop 
algorithms based on full text, including: (1) retrieving the PDF files of numerous papers automatically 
(including resolving access issues), (2) automatically extracting text, figures, and tables from a PDF or other 
published format, and (3) developing more complex classification models for additional labels.  
 As we have shown, the CNN model did not outperform the SVM model. This is true for both 
classification tasks and is not surprising, as neural networks typically require much larger amounts of annotated 
data for training.  As an alternative to annotating more data, one may further improve model performance by 
asking human annotators to provide justifications for their decisions28. These justifications can be in the form of 
highlighting parts of the original input abstract that informed the classification decision. Recently, Bao et al. and 
Zhang et al. showed that providing these justifications to the model can significantly improve classification 
performance when limited amount of training data are available.27,29  
 In this study, we developed two models to classify abstracts relevant to the penetrance or prevalence of 
cancer susceptibility genes. Our models achieve high performance and have the potential to reduce the literature 
review burden. With the exponential growth of the medical literature, our hope is to use computing power to 
help clinicians and researchers search for and prioritize knowledge in this field and to keep knowledge bases 
that are used by Clinical Decision Support tools, such as ASK2ME1,18, up to date. 
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FIGURE LEGENDS 
Figure 1. Receiver operating characteristic curve for (a) penetrance classification, and (b) prevalence 
classification. 
Figure 2. Learning rate of the two models on the task of (a) penetrance classification, and (b) prevalence 
classification. 
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TABLES 
Table 1. Summary of the annotated dataset 
 Number of Positive 
Papers 
Number of Negative 
Papers 
Original Dataset 
Penetrance 989 2930 
Prevalence 1291 2628 
Polymorphism 295 3624 
Ambiguous penetrance 119 3800 
Ambiguous prevalence 101 3818 
After Excluding Polymorphism and Ambiguous Papers 
Penetrance 904 2836 
Prevalence 1230 2523 
 
Table 2. Performance of two NLP models developed for penetrance and prevalence classification 
Task Penetrance Classification Prevalence Classification 
 Accuracy (95%CI) F1 Score (95%CI) Accuracy (95%CI) F1 Score (95%CI) 
SVM 
0.8953 (0.8919, 
0.8987) 
0.7886 (0.7779, 
0.7993) 
0.8914 (0.8863, 
0.8965) 
0.8396 (0.8334, 
0.8458) 
CNN 0.8895 (0.8855, 
0.8935) 
0.7544 (0.7368, 
0.7720) 
0.8913 (0.8859, 
0.8967) 
0.8348 (0.8281, 
0.8415) 
CI: confidence interval. SVM: support vector machine. CNN: convolutional neural network
 
